This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Rubin Bressler, MD; David G. Johnson, MD

Arch Intern Med. 1997;157(8):836-848.

Abstract
Non—insulin-dependent diabetes mellitus is a metabolic disease that is common and is characterized by insulin insufficiency and resistance. Measures such as body weight reduction and exercise improve the metabolic defects, but pharmacological therapy is the most frequently used and successful therapy. The sulphonylureas stimulate insulin secretion. Metformin and troglitazone increase disposal and decrease hepatic glucose output without causing hypoglycemia. Acarbose is a dietary aid that spreads the dietary carbohydrate challenge to endogenous insulin over time. These pharmacological agents, either alone or in combination, can improve blood glucose regulation in patients with non—insulin-dependent diabetes mellitus.

Arch Intern Med. 1997;157:836-848

Author Affiliations
From the Departments of Medicine and Pharmacology, University of Arizona Health Sciences Center, Tucson.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Trends in the Prescribing of Oral Agents for the Management of Type 2 Diabetes Mellitus in the United States, 1990-2001: Does Type of Insurance Influence Access to Innovation?
Skaer et al.
The Diabetes Educator 2006;32:940-953.
ABSTRACT | FULL TEXT  

Prevention and Treatment of Type 2 Diabetes Mellitus in Children, With Special Emphasis on American Indian and Alaska Native Children
Gahagan et al.
Pediatrics 2003;112:e328-e328.
ABSTRACT | FULL TEXT  

The 25-kDa Synaptosome-associated Protein (SNAP-25) Binds and Inhibits Delayed Rectifier Potassium Channels in Secretory Cells
Ji et al.
J. Biol. Chem. 2002;277:20195-20204.
ABSTRACT | FULL TEXT  

Management of Type 2 Diabetes in the Geriatric Patient
Campbell
Journal of Pharmacy Practice 2000;13:263-276.
ABSTRACT  

Sulfonylurea Pharmacotherapy Regimen Adherence in a Medicaid Population: Influence of Age, Gender, and Race
Sclar et al.
The Diabetes Educator 1999;25:531-538.
 

Mechanisms of Vasorelaxation Induced by Troglitazone, a Novel Antidiabetic Drug, in the Porcine Coronary Artery
Kawasaki et al.
Circulation 1998;98:2446-2452.
ABSTRACT | FULL TEXT  

Pathophysiology of Type 2 Diabetes and Modes of Action of Therapeutic Interventions
Dagogo-Jack and Santiago
Arch Intern Med 1997;157:1802-1817.
ABSTRACT